Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.
Zhuang W, Bai H, Zhao J, Li W, Yu J, Wang Z, Duan J, Hao X, Wang Y, Liu Y, Wang L, Lin L, Wan R, Sun B, Xu J, Fei K, Fan Y, He W, Liu Z, Fan L, He D, Gao R, Yang Y, Ying J, Zhong J, Wang J.
Zhuang W, et al. Among authors: li w.
Sci China Life Sci. 2026 May 11. doi: 10.1007/s11427-025-3266-x. Online ahead of print.
Sci China Life Sci. 2026.
PMID: 42144506